147 related articles for article (PubMed ID: 9079636)
1. Characterization of ligand binding of a soluble human insulin-like growth factor I receptor variant suggests a ligand-induced conformational change.
Jansson M; Hallén D; Koho H; Andersson G; Berghard L; Heidrich J; Nyberg E; Uhlén M; Kördel J; Nilsson B
J Biol Chem; 1997 Mar; 272(13):8189-97. PubMed ID: 9079636
[TBL] [Abstract][Full Text] [Related]
2. Structural changes in insulin-like growth factor (IGF) I mutant proteins affecting binding kinetic rates to IGF binding protein 1 and IGF-I receptor.
Jansson M; Uhlen M; Nilsson B
Biochemistry; 1997 Apr; 36(14):4108-17. PubMed ID: 9100004
[TBL] [Abstract][Full Text] [Related]
3. Binding affinities of insulin-like growth factor-I (IGF-I) fusion proteins to IGF binding protein 1 and IGF-I receptor are not correlated with mitogenic activity.
Jansson M; Dixelius J; Uhlen M; Nilsson BO
FEBS Lett; 1997 Oct; 416(3):259-64. PubMed ID: 9373165
[TBL] [Abstract][Full Text] [Related]
4. An investigation of the ligand binding properties and negative cooperativity of soluble insulin-like growth factor receptors.
Surinya KH; Forbes BE; Occhiodoro F; Booker GW; Francis GL; Siddle K; Wallace JC; Cosgrove LJ
J Biol Chem; 2008 Feb; 283(9):5355-63. PubMed ID: 18056713
[TBL] [Abstract][Full Text] [Related]
5. Solution structure of ectodomains of the insulin receptor family: the ectodomain of the type 1 insulin-like growth factor receptor displays asymmetry of ligand binding accompanied by limited conformational change.
Whitten AE; Smith BJ; Menting JG; Margetts MB; McKern NM; Lovrecz GO; Adams TE; Richards K; Bentley JD; Trewhella J; Ward CW; Lawrence MC
J Mol Biol; 2009 Dec; 394(5):878-92. PubMed ID: 19835884
[TBL] [Abstract][Full Text] [Related]
6. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
Denley A; Carroll JM; Brierley GV; Cosgrove L; Wallace J; Forbes B; Roberts CT
Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
[TBL] [Abstract][Full Text] [Related]
7. Binding specificities and transducing function of the different molecular weight forms of insulin-like growth factor-II (IGF-II) on IGF-I receptors.
Perdue JF; LeBon TR; Kato J; Hampton B; Fujita-Yamaguchi Y
Endocrinology; 1991 Dec; 129(6):3101-8. PubMed ID: 1659523
[TBL] [Abstract][Full Text] [Related]
8. Rabbit slow and fast skeletal muscle-derived satellite myoblast phenotypes do not involve constitutive differences in the components of the insulin-like growth factor system.
Barjot C; Navarro M; Cotten ML; Garandel V; Bernardi H; Bacou F; Barenton B
J Cell Physiol; 1996 Nov; 169(2):227-34. PubMed ID: 8908189
[TBL] [Abstract][Full Text] [Related]
9. Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells.
Ellis MJ; Leav BA; Yang Z; Rasmussen A; Pearce A; Zweibel JA; Lippman ME; Cullen KJ
Mol Endocrinol; 1996 Mar; 10(3):286-97. PubMed ID: 8833657
[TBL] [Abstract][Full Text] [Related]
10. Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved.
Pandini G; Frasca F; Mineo R; Sciacca L; Vigneri R; Belfiore A
J Biol Chem; 2002 Oct; 277(42):39684-95. PubMed ID: 12138094
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of insulin-like growth factor (IGF)-binding protein-3 and its proteolytic fragments on ligand binding, cell surface association, and IGF-I receptor signaling.
Devi GR; Yang DH; Rosenfeld RG; Oh Y
Endocrinology; 2000 Nov; 141(11):4171-9. PubMed ID: 11089550
[TBL] [Abstract][Full Text] [Related]
12. Insulin-Insulin-like Growth Factors Hybrids as Molecular Probes of Hormone:Receptor Binding Specificity.
Křížková K; Chrudinová M; Povalová A; Selicharová I; Collinsová M; Vaněk V; Brzozowski AM; Jiráček J; Žáková L
Biochemistry; 2016 May; 55(21):2903-13. PubMed ID: 27171135
[TBL] [Abstract][Full Text] [Related]
13. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
Reeve JG; Morgan J; Schwander J; Bleehen NM
Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of hybrid receptors composed of a truncated insulin receptor and wild type insulin-like growth factor 1 or insulin receptors.
Langlois WJ; Sasaoka T; Yip CC; Olefsky JM
Endocrinology; 1995 May; 136(5):1978-86. PubMed ID: 7720646
[TBL] [Abstract][Full Text] [Related]
15. Recombinant adenoviruses expressing dominant negative insulin-like growth factor-I receptor demonstrate antitumor effects on lung cancer.
Lee CT; Park KH; Adachi Y; Seol JY; Yoo CG; Kim YW; Han SK; Shim YS; Coffee K; Dikov MM; Carbone DP
Cancer Gene Ther; 2003 Jan; 10(1):57-63. PubMed ID: 12489029
[TBL] [Abstract][Full Text] [Related]
16. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix.
Arai T; Busby W; Clemmons DR
Endocrinology; 1996 Nov; 137(11):4571-5. PubMed ID: 8895319
[TBL] [Abstract][Full Text] [Related]
17. Signaling-competent receptor chimeras allow mapping of major insulin receptor binding domain determinants.
Schumacher R; Soos MA; Schlessinger J; Brandenburg D; Siddle K; Ullrich A
J Biol Chem; 1993 Jan; 268(2):1087-94. PubMed ID: 7678247
[TBL] [Abstract][Full Text] [Related]
18. Engineering the C-region of human insulin-like growth factor-1: implications for receptor binding.
Gill R; Wallach B; Verma C; Ursø B; De Wolf E; Grötzinger J; Murray-Rust J; Pitts J; Wollmer A; De Meyts P; Wood S
Protein Eng; 1996 Nov; 9(11):1011-9. PubMed ID: 8961354
[TBL] [Abstract][Full Text] [Related]
19. Binding properties of insulin-like growth factor binding protein-3 (IGFBP-3), IGFBP-3 N- and C-terminal fragments, and structurally related proteins mac25 and connective tissue growth factor measured using a biosensor.
Vorwerk P; Hohmann B; Oh Y; Rosenfeld RG; Shymko RM
Endocrinology; 2002 May; 143(5):1677-85. PubMed ID: 11956149
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of binding of insulin-like growth factor (IGF)-I and IGF-II analogues to the type 1 IGF receptor determined by BIAcore analysis.
Forbes BE; Hartfield PJ; McNeil KA; Surinya KH; Milner SJ; Cosgrove LJ; Wallace JC
Eur J Biochem; 2002 Feb; 269(3):961-8. PubMed ID: 11846798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
